132 related articles for article (PubMed ID: 37293777)
1. Consensus survey on the management of children with chemotherapy-induced febrile neutropenia and at low risk of severe infection.
Givone A; Duval-Destin J; Delebarre M; Abou-Chahla W; Lervat C; Dubos F
Pediatr Hematol Oncol; 2024; 41(2):172-178. PubMed ID: 37293777
[TBL] [Abstract][Full Text] [Related]
2. Survey of practices for the clinical management of febrile neutropenia in children in hematology-oncology units in Latin America.
Melgar MA; Homsi MR; Happ B; Su Y; Tang L; Gonzalez ML; Caniza MA
Support Care Cancer; 2021 Dec; 29(12):7903-7911. PubMed ID: 34189607
[TBL] [Abstract][Full Text] [Related]
3. Risk-stratification management of febrile neutropenia in pediatric hematology-oncology patients: Results of a French nationwide survey.
Delebarre M; Tiphaine A; Martinot A; Dubos F
Pediatr Blood Cancer; 2016 Dec; 63(12):2167-2172. PubMed ID: 27569451
[TBL] [Abstract][Full Text] [Related]
4. Supportive therapies in the prevention of chemotherapy-induced febrile neutropenia and appropriate use of granulocyte colony-stimulating factors: a Delphi consensus statement.
Adamo V; Antonuzzo L; Danova M; De Laurentiis M; Marchetti P; Pinto C; Rosti G
Support Care Cancer; 2022 Dec; 30(12):9877-9888. PubMed ID: 36334157
[TBL] [Abstract][Full Text] [Related]
5. Very early discharge versus early discharge versus non-early discharge in children with cancer and febrile neutropenia.
Loeffen EA; Te Poele EM; Tissing WJ; Boezen HM; de Bont ES
Cochrane Database Syst Rev; 2016 Feb; 2(2):CD008382. PubMed ID: 26899263
[TBL] [Abstract][Full Text] [Related]
6. Management of chemotherapy-induced febrile neutropenia in pediatric oncology patients: A North American survey of pediatric hematology/oncology and pediatric infectious disease physicians.
Maxwell RR; Egan-Sherry D; Gill JB; Roth ME
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28748605
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the safety and effectiveness of PegaGen
Jenabian A; Ehsanpour A; Mortazavizadeh SMR; Raafat J; Razavi M; Khosravi A; Seifi S; Salimi B; Anjidani N; Kafi H
Support Care Cancer; 2022 Oct; 30(10):8151-8158. PubMed ID: 35792924
[TBL] [Abstract][Full Text] [Related]
8. Consensus document on the management of febrile neutropenia in paediatric haematology and oncology patients of the Spanish Society of Pediatric Infectious Diseases (SEIP) and the Spanish Society of Pediatric Hematology and Oncology (SEHOP).
Martínez Campos L; Pérez-Albert P; Ferres Ramis L; Rincón-López EM; Mendoza-Palomar N; Soler-Palacin P; Aguilera-Alonso D; ; ;
An Pediatr (Engl Ed); 2023 Jun; 98(6):446-459. PubMed ID: 37268527
[TBL] [Abstract][Full Text] [Related]
9. Emergency department management of chemotherapy related febrile neutropenia: An opportunity to improve care.
Pettit N; Boadu D; Bischof JJ
Am J Emerg Med; 2021 Dec; 50():5-9. PubMed ID: 34265732
[TBL] [Abstract][Full Text] [Related]
10. Oral Step-Down Therapy With Levofloxacin for Febrile Neutropenia in Children With Cancer.
Olson J; Mehra S; Hersh AL; Thorell EA; Stoddard GJ; Maese L; Barnette PE; Lemons RS; Pavia AT; Knackstedt ED
J Pediatric Infect Dis Soc; 2021 Feb; 10(1):27-33. PubMed ID: 32092134
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of pegfilgrastim versus filgrastim for prevention of chemotherapy-induced febrile neutropenia in patients with lymphoma: a systematic review.
Gebremariam GT; Fentie AM; Beyene K; Sander B; Gebretekle GB
BMC Health Serv Res; 2022 Dec; 22(1):1600. PubMed ID: 36585648
[TBL] [Abstract][Full Text] [Related]
12. Difference of compliance rates for the recommendations in Japanese Guideline on Febrile Neutropenia according to respondents' attributes: the second report on a questionnaire survey among hematology-oncology physicians and surgeons.
Akiyama N; Okamura T; Yoshida M; Kimura SI; Yano S; Yoshida I; Kusaba H; Takahashi K; Fujita H; Fukushima K; Iwasaki H; Tamura K; Saeki T; Takamatsu Y; Zenda S
Support Care Cancer; 2022 May; 30(5):4327-4336. PubMed ID: 35094140
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of step-down to oral outpatient treatment versus inpatient antimicrobial treatment in pediatric cancer patients with febrile neutropenia: A noninferiority multicenter randomized clinical trial.
Avilés-Robles MJ; Reyes-López A; Otero-Mendoza FJ; Valencia-Garin AU; Peñaloza-González JG; Rosales-Uribe RE; Muñoz-Hernández O; Garduño-Espinosa J; Juárez-Villegas L; Zapata-Tarrés M
Pediatr Blood Cancer; 2020 Jun; 67(6):e28251. PubMed ID: 32196898
[TBL] [Abstract][Full Text] [Related]
14. Early discharge of pediatric patients with cancer, fever, and neutropenia with low-risk of systemic infection.
Gil-Veloz M; Pacheco-Rosas DO; Solórzano-Santos F; Villasís-Keever MA; Betanzos-Cabrera Y; Miranda-Novales G
Bol Med Hosp Infant Mex; 2018; 75(6):352-357. PubMed ID: 30407457
[TBL] [Abstract][Full Text] [Related]
15. [Febrile neutropenia in cancer patients: management in the emergency room].
Rivera-Salgado D; Valverde-Muñoz K; Ávila-Agüero ML
Rev Chilena Infectol; 2018; 35(1):62-71. PubMed ID: 29652973
[TBL] [Abstract][Full Text] [Related]
16. [Modalities of management of cancer patients with febrile neutropenia in the oncology emergency unit of Gustave-Roussy and their related costs].
Borget I; Antoun S; Chachaty E; Gachot B; Alibay A; Di Palma M; Merad M
Bull Cancer; 2014 Oct; 101(10):925-31. PubMed ID: 25373692
[TBL] [Abstract][Full Text] [Related]
17. Outpatient versus inpatient IV antibiotic management for pediatric oncology patients with low risk febrile neutropenia: a randomised trial.
Orme LM; Babl FE; Barnes C; Barnett P; Donath S; Ashley DM
Pediatr Blood Cancer; 2014 Aug; 61(8):1427-33. PubMed ID: 24604835
[TBL] [Abstract][Full Text] [Related]
18. [Chemotherapy-induced febrile neutropenia in a Tunisian Department of Pediatric Oncology].
Fedhila F; Ahmed SB; Jbebli E; Mezghani F; Haddad S; Rhayem S; Khemiri M
Pan Afr Med J; 2022; 42():34. PubMed ID: 35910049
[TBL] [Abstract][Full Text] [Related]
19. A Randomized, Open-Labeled, Prospective Controlled Study to Assess the Efficacy of Frontline Empirical Intravenous Piperacillin/Tazobactam Monotherapy in Comparison with Ceftazidime Plus Amikacin for Febrile Neutropenia in Pediatric Oncology Patients.
Kamonrattana R; Sathitsamitphong L; Choeyprasert W; Charoenkwan P; Natesirinilkul R; Fanhchaksai K
Asian Pac J Cancer Prev; 2019 Sep; 20(9):2733-2737. PubMed ID: 31554370
[TBL] [Abstract][Full Text] [Related]
20. A questionnaire survey on evaluation for penetration and compliance of the Japanese Guideline on Febrile Neutropenia among hematology-oncology physicians and surgeons.
Akiyama N; Okamura T; Yoshida M; Kimura SI; Yano S; Yoshida I; Kusaba H; Takahashi K; Fujita H; Fukushima K; Iwasaki H; Tamura K; Saeki T; Takamatsu Y; Zenda S
Support Care Cancer; 2021 Nov; 29(11):6831-6839. PubMed ID: 34008079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
